ACRIN 6684: Phase II Assessment of Tumor Hypoxia in Glioblastoma Using FMISO with PET and MRI (R09-185)

Grant

Date/time Interval

  • September 1, 2010 - February 28, 2014
  • Total Award Amount

  • 20269.00
  • Direct Costs

  • 16086.00
  • Sponsor Award Id

  • ACRIN 6684